Klinisk Tandtekniker Birgitte Frydensberg ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.4% 4.7% 4.3% 4.1% 3.4%  
Credit score (0-100)  43 45 46 48 53  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  814 812 855 870 1,265  
EBITDA  224 166 179 82.0 207  
EBIT  159 91.4 104 7.1 138  
Pre-tax profit (PTP)  126.2 79.5 93.0 -3.1 95.4  
Net earnings  97.8 67.0 67.5 -2.7 71.1  
Pre-tax profit without non-rec. items  126 79.5 93.0 -3.1 95.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  159 121 84.3 47.1 494  
Shareholders equity total  186 253 321 261 273  
Interest-bearing liabilities  421 121 82.8 98.2 500  
Balance sheet total (assets)  820 620 590 580 979  

Net Debt  332 72.4 36.8 14.0 416  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  814 812 855 870 1,265  
Gross profit growth  0.0% -0.3% 5.3% 1.7% 45.5%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  820 620 590 580 979  
Balance sheet change%  0.0% -24.4% -4.8% -1.6% 68.8%  
Added value  224.3 166.3 178.9 82.0 207.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  434 -150 -150 -150 340  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  19.6% 11.3% 12.2% 0.8% 10.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  19.4% 12.7% 17.2% 1.2% 17.8%  
ROI %  22.9% 16.0% 22.7% 1.6% 22.2%  
ROE %  52.6% 30.5% 23.5% -0.9% 26.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  22.7% 40.8% 54.3% 44.9% 27.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  148.1% 43.5% 20.6% 17.1% 200.8%  
Gearing %  226.2% 48.0% 25.8% 37.7% 183.4%  
Net interest  0 0 0 0 0  
Financing costs %  15.7% 4.4% 10.9% 11.2% 14.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.7 1.0 1.4 1.0 1.1  
Current Ratio  0.8 1.1 1.5 1.2 1.3  
Cash and cash equivalent  88.6 49.0 46.0 84.2 84.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -63.5 24.1 81.2 41.1 75.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  224 166 179 82 207  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  224 166 179 82 207  
EBIT / employee  159 91 104 7 138  
Net earnings / employee  98 67 67 -3 71